Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-09T20:01:38.914Z Has data issue: false hasContentIssue false

Chapter 11 - Medication Assisted Treatment for Opioid Use Disorder during Pregnancy

from Section 2 - Antepartum and Intrapartum Care

Published online by Cambridge University Press:  08 June 2018

By
Lawrence Leeman  and
Jacquelyn Starer
Edited by
Tricia E. Wright
Tricia E. Wright
Affiliation:
University of Hawaii, Manoa
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Opioid-Use Disorders in Pregnancy
Management Guidelines for Improving Outcomes
 , pp. 84 - 92
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Jones, H. E., Martin, P. R., Heil, S. H., et al. Treatment of opioid-dependent pregnant women: clinical and research issues. Journal of Substance Abuse Treatment. Oct 2008;35(3):245–59.Google Scholar
Joseph, H., Dole, V. P. Methadone patients on probation and parole. Federal probation. Jun 1970;34:42–8.Google Scholar
Dole, V. P., Nyswander, M. A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride. JAMA. Aug 23 1965;193:646–50.Google Scholar
Blinick, G., Jerez, E., Wallach, R. C. Methadone maintenance, pregnancy, and progeny. JAMA. Jul 30 1973;225(5):477–9.CrossRefGoogle ScholarPubMed
Treatment CfSA. Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Treatment Improvement Protocol (TIP) Series, No. 43. Center for Substance Abuse Treatment. Rockville, MD: Substance Abuse and Mental Health Services Administration (US); 2005.Google Scholar
Hartel, D. M., Schoenbaum, E. E. Methadone Treatment Protects against HIV Infection: Two Decades of Experience in the Bronx, New York City. Public Health Reports (Washington, D.C.: 1974). Jun 1998;113(Suppl 1):107–15.Google Scholar
Treatment CfSA. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series, No. 40. Center for Substance Abuse Treatment. Rockville, MD: Substance Abuse and Mental Health Services Administration (US); 2004.Google Scholar
Jones, H. E., Kaltenbach, K., Heil, S. H., et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. The New England Journal of Medicine. Dec 9 2010;363(24):2320–31.CrossRefGoogle ScholarPubMed
ACOG Committee. Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy. Obstetrics and Gynecology. May 2012;119(5):1070–6.Google Scholar
SAMHSA. Certification of Opioid Treatment Programs (OTPs). 2015; www.samhsa.gov/medication-assisted-treatment/opioid-treatment-programs. Accessed January 6, 2017.Google Scholar
American Society of Addiction Medicine. Nurse Practitioners and Physician Assistants Prescribing Buprenorphine. www.asam.org/quality-practice/practice-resources/nurse-practitioners-and-physician-assistants-prescribing-buprenorphine. Accessed February 25, 2017.Google Scholar
Pond, S. M., Kreek, M. J., Tong, T. G., Raghunath, J., Benowitz, N. L. Altered methadone pharmacokinetics in methadone-maintained pregnant women. The Journal of Pharmacology and Experimental Therapeutics. Apr 1985;233(1):1–6.Google Scholar
McCarthy, J. J., Leamon, M. H., Willits, N. H., Salo, R. The effect of methadone dose regimen on neonatal abstinence syndrome. Journal of Addiction Medicine. Mar–Apr 2015;9(2):105–10.CrossRefGoogle ScholarPubMed
Cleary, B. J., Donnelly, J., Strawbridge, J., et al. Methadone dose and neonatal abstinence syndrome – systematic review and meta-analysis. Addiction (Abingdon, England). Dec 2010;105(12):2071–84.Google Scholar
American Academy of Pediatrics Committee on Drugs: The transfer of drugs and other chemicals into human milk. Pediatrics. Jan 1994;93(1):137–50.Google Scholar
Jansson, L. M., Choo, R., Velez, M. L., et al. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics. Jan 2008;121(1):106–14.Google ScholarPubMed
American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. Sep 2001;108(3):776–89.Google Scholar
McCarthy, J. J. Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus? The Journal of Maternal-Fetal & Neonatal Medicine: The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. Feb 2012;25(2):109–12.Google Scholar
Mannelli, P., Peindl, K. S., Lee, T., Bhatia, K. S., Wu, L. T. Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives. Current Drug Abuse Reviews. Mar 2012;5(1):52–63.CrossRefGoogle ScholarPubMed
Debelak, K., Morrone, W. R., O'Grady, K. E., Jones, H. E. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy–initial patient care and outcome data. The American Journal on Addictions. May–Jun 2013;22(3):252–4.Google Scholar
Wiegand, S. L., Stringer, E. M., Stuebe, A. M., et al. Buprenorphine and naloxone compared with methadone treatment in pregnancy. Obstetrics and Gynecology. Feb 2015;125(2):363–8.CrossRefGoogle ScholarPubMed
Rosenthal, R. N., Lofwall, M. R., Kim, S., et al. Effect of buprenorphine implants on illicit opioid use among abstinent adults with opioid dependence treated with sublingual buprenorphine: a randomized clinical trial. JAMA. Jul 19 2016;316(3):282–90.Google Scholar
Sigmon, S. C., Bigelow, G. E. Food and Drug Administration approval of sustained-release buprenorphine for treatment of opioid dependence: realizing its potential. Addiction (Abingdon, England). Mar 2017;112(3):386–7.Google Scholar
Jones, H. E., Chisolm, M. S., Jansson, L. M., Terplan, M. Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research. Addiction (Abingdon, England). Feb 2013;108(2):233–47.Google Scholar
Saia, K. A., Schiff, D., Wachman, E. M., et al. Caring for pregnant women with opioid use disorder in the USA: expanding and improving treatment. Current Obstetrics and Gynecology Reports. 2016;5:257–63.Google Scholar
Jones, H. E. Acceptance of naltrexone by pregnant women enrolled in comprehensive drug addiction treatment: an initial survey. The American Journal on Addictions. May–Jun 2012;21(3):199–201.CrossRefGoogle ScholarPubMed
Jones, H. E., O'Grady, K. E., Malfi, D., Tuten, M. Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. The American Journal on Addictions. Sep–Oct 2008;17(5):372–86.CrossRefGoogle ScholarPubMed
Bell, J., Towers, C. V., Hennessy, M. D., et al. Detoxification from opiate drugs during pregnancy. American Journal of Obstetrics and Gynecology. Sep 2016;215(3):374. e371–76.CrossRefGoogle ScholarPubMed
Rementeria, J. L., Nunag, N. N. Narcotic withdrawal in pregnancy: stillbirth incidence with a case report. American Journal of Obstetrics and Gynecology. Aug 15 1973;116(8):1152–6.Google Scholar
Zuspan, F. P., Gumpel, J. A., Mejia-Zelaya, A., Madden, J., Davis, R. Fetal stress from methadone withdrawal. American Journal of Obstetrics and Gynecology. May 1 1975;122(1):43–6.Google Scholar
Luty, J., Nikolaou, V., Bearn, J. Is opiate detoxification unsafe in pregnancy? Journal of Substance Abuse Treatment. Jun 2003;24(4):363–7.CrossRefGoogle ScholarPubMed
Welle-Strand, G. K., Skurtveit, S., Tanum, L., et al. Tapering from methadone or buprenorphine during pregnancy: maternal and neonatal outcomes in Norway 1996–2009. European Addiction Research. 2015;21(5):253–61.CrossRefGoogle ScholarPubMed
Alto, W. A., O'Connor, A. B. Management of women treated with buprenorphine during pregnancy. American Journal of Obstetrics and Gynecology. Oct 2011;205(4):302–8.Google Scholar
Hudak, M. L., Tan, R. C. Neonatal drug withdrawal. Pediatrics. Feb 2012;129(2):e540–60.CrossRefGoogle ScholarPubMed
Holbrook, A. M., Jones, H. E., Heil, S. H., et al. Induction of pregnant women onto opioid-agonist maintenance medication: an analysis of withdrawal symptoms and study retention. Drug and Alcohol Dependence. Sep 1 2013;132(1–2):329–34.CrossRefGoogle ScholarPubMed
Srivastava, A., Kahan, M. Methadone induction doses: are our current practices safe? Journal of Addictive Diseases. 2006;25(3):5–13.Google Scholar
McCance-Katz, E. F., Sullivan, L. E., Nallani, S. Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review. The American Journal on Addictions. Jan–Feb 2010;19(1):4–16.CrossRefGoogle ScholarPubMed
Chou, R., Cruciani, R. A., Fiellin, D. A., et al. Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society. The Journal of Pain: Official Journal of the American Pain Society. Apr 2014;15(4):321–37.Google ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×